Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community

Figures & data

Fig. 1 Impact of substandard and falsified medical products. Source: WHO Geneva. 2017

Fig. 2 SF PDR approach included in policy documents

Fig. 3 Allocation of funds for medical product sampling

Availability of data and materials

The datasets used and analysed during the study that is the main basis for the review are available from the corresponding author on reasonable request.